Interleukin-23 levels in umbilical cord blood are associated with neurodevelopmental trajectories in infancy

PLoS One. 2024 Apr 9;19(4):e0301982. doi: 10.1371/journal.pone.0301982. eCollection 2024.

Abstract

Our previous study, which aimed to understand the early neurodevelopmental trajectories of children with and without neurodevelopmental disorders, identified five classes of early neurodevelopmental trajectories, categorized as high normal, normal, low normal, delayed, and markedly delayed. This investigation involved measurement using the Mullen Scale of Early Learning in a representative sample of Japanese infants followed up from the age of 0 to 2 years (Nishimura et al., 2016). In the present study, we investigated the potential association between cytokine concentrations in umbilical cord serum with any of the five classes of neurodevelopmental trajectories previously assigned, as follows: high normal (N = 85, 13.0%), normal (N = 322, 49.1%), low normal (N = 137, 20.9%), delayed (N = 87, 13.3%), and markedly delayed (N = 25, 3.8%) in infancy. Decreased interleukin (IL)-23 levels in the cord blood were associated with the markedly delayed class, independent of potential confounders (odds ratio, 0.44; 95%confidence interval: 0.26-0.73). Furthermore, IL-23 levels decreased as the developmental trajectory became more delayed, demonstrating that IL-23 plays an important role in development, and is useful for predicting the developmental trajectory at birth.

MeSH terms

  • Child, Preschool
  • Cytokines
  • Fetal Blood*
  • Humans
  • Infant
  • Infant, Newborn
  • Interleukin-23
  • Neurodevelopmental Disorders*
  • Umbilical Cord

Substances

  • Cytokines
  • Interleukin-23

Grants and funding

This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (https://www.mext.go.jp/en/index.htm, JP20K07941 to TN; JP20H03601 to HK; JP21K07479 to NT; JP19H03582, JP21KK0145, and JP22H00492 to KJT), Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/index.html, JP21gk0110039 and 23gn0110079h0001 to KJT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.